Emmessar Biotech & Nutrition Limited (EMMESSA.BO)
INR 44.98
(4.6%)
INR 44.98
(4.6%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 5.55 Million | 10.19 Million | 3.64 Million | 69.9 Million | 33.95 Million | 6.29 Million |
| Cost of Revenue | 12.98 Million | 3.99 Million | 1.25 Million | 35.32 Million | 15.4 Million | 1.24 Million |
| Gross Profit | -7.43 Million | 6.19 Million | 2.39 Million | 34.58 Million | 18.55 Million | 5.05 Million |
| Operating Expenses | 4.32 Million | 13.82 Million | 11.58 Million | 26.67 Million | 23.18 Million | 12.22 Million |
| Selling, General and Administrative Expenses | 1.25 Million | 1.2 Million | 1.17 Million | 801.23 Thousand | 767.25 Thousand | 840.52 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 3.07 Million | 14.86 Million | 14.06 Million | 13.51 Million | 14.65 Million | 12.63 Million |
| Cost and Expenses | 17.3 Million | 17.82 Million | 12.84 Million | 61.99 Million | 38.59 Million | 13.46 Million |
| Operating Income | -11.75 Million | -7.68 Million | -9.53 Million | 7.9 Million | -4.61 Million | -7.17 Million |
| Interest Expense | - | 13 Thousand | 10.46 Thousand | 15.37 Thousand | 24.21 Thousand | 15.34 Thousand |
| Income Tax Expense | 630 Thousand | 4.63 Million | 4.56 Million | 8.04 Million | -161 Thousand | -2.39 Million |
| Earnings before Tax | 8.12 Million | 9.66 Million | 9.31 Million | 22.54 Million | 7.37 Million | 2.93 Million |
| Net Income | 7.49 Million | 5.03 Million | 4.75 Million | 14.49 Million | 7.53 Million | 5.32 Million |
| Earnings Per Share Basic | 1.48 | 1.01 | 0.95 | 2.90 | 1.51 | 1.07 |
| Earnings Per Share Diluted | 1.48 | 1.01 | 0.95 | 2.90 | 1.51 | 1.07 |
| Weighted Average Shares Outstanding | 5.06 Million | 4.99 Million | 4.99 Million | 4.99 Million | 4.99 Million | 4.99 Million |
| Weighted Average Shares Outstanding (Diluted) | 5.06 Million | 4.99 Million | 4.99 Million | 4.99 Million | 4.99 Million | 4.99 Million |
| Gross Margin | -1.34 | 0.61 | 0.66 | 0.49 | 0.55 | 0.80 |
| EBIT Margin | -1.95 | -0.67 | -2.94 | 0.12 | -0.04 | -0.56 |
| Profit Margin | 1.35 | 0.49 | 1.30 | 0.21 | 0.22 | 0.85 |
| EBITDA | -10.81 Million | -6.9 Million | -10.71 Million | 8.48 Million | -4.05 Million | -6.38 Million |
| Earnings Before Tax Margin | -2.12 | -0.75 | -2.61 | 0.11 | -0.14 | -1.14 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 792 Thousand | 753 Thousand | 5.55 Million | 3.27 Million | 843 Thousand | 677 Thousand |
| Cost of Revenue | 2.8 Million | 2.89 Million | 12.52 Million | 1.39 Million | 233 Thousand | 159 Thousand |
| Gross Profit | -2 Million | -2.13 Million | -6.97 Million | 1.88 Million | 610 Thousand | 518 Thousand |
| Operating Expenses | 983 Thousand | 2.03 Million | 4.82 Million | 4.18 Million | 3 Million | 3.49 Million |
| Selling, General and Administrative Expenses | 983 Thousand | 2.03 Million | - | 1.04 Million | 615 Thousand | 1.02 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 4.57 Million | 4.84 Million | 19.92 Million | 5.25 Million | 5.27 Million | 4.57 Million |
| Cost and Expenses | 3.78 Million | 4.92 Million | 17.34 Million | 5.58 Million | 3.24 Million | 3.65 Million |
| Operating Income | -2.99 Million | -4.16 Million | -11.79 Million | -2.3 Million | -2.39 Million | -2.97 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 694 Thousand | -3.01 Million | 630 Thousand | 1.65 Million | 901 Thousand | 1.04 Million |
| Earnings before Tax | 1.58 Million | 667 Thousand | 8.12 Million | 2.94 Million | 2.87 Million | 1.59 Million |
| Net Income | 890 Thousand | 3.68 Million | 7.49 Million | 1.28 Million | 1.97 Million | 549 Thousand |
| Earnings Per Share Basic | 0.18 | 0.71 | - | 0.26 | 0.39 | 0.11 |
| Earnings Per Share Diluted | 0.18 | 0.71 | - | 0.26 | 0.39 | 0.11 |
| Weighted Average Shares Outstanding | 4.99 Million | 4.99 Million | 4.99 Million | 4.99 Million | 4.99 Million | 4.99 Million |
| Weighted Average Shares Outstanding (Diluted) | 4.99 Million | 4.99 Million | 4.99 Million | 4.99 Million | 4.99 Million | 4.99 Million |
| Gross Margin | -2.54 | -2.84 | -1.26 | 0.57 | 0.72 | 0.77 |
| EBIT Margin | -3.47 | -5.21 | - | -0.63 | -2.56 | -4.04 |
| Profit Margin | 1.12 | 4.89 | 1.35 | 0.39 | 2.34 | 0.81 |
| EBITDA | -2.74 Million | -3.92 Million | - | -2.06 Million | -2.15 Million | -2.73 Million |
| Earnings Before Tax Margin | -3.78 | -5.54 | -2.12 | -0.70 | -2.84 | -4.40 |
MEQYF
3913
STX
4506
1376
TRANSFRE